Literature DB >> 25594638

Plasma osteopontin predicts inflammatory bowel disease activities.

Shihoko Komine-Aizawa1, Hideki Masuda, Takerou Mazaki, Motomi Shiono, Satoshi Hayakawa, Tadatoshi Takayama.   

Abstract

A glycoprotein osteopontin (OPN) is involved in inflammatory diseases, but its roles in inflammatory bowel disease (IBD) are controversial. To analyze the involvement of the systemic immune response, we simultaneously examined plasma OPN levels and 17 cytokines. This study included 24 ulcerative colitis (UC) patients, 17 Crohn's disease (CD) patients, and 23 normal controls. Clinical parameters were also examined. The plasma OPN levels of the UC and CD patients were significantly higher than those of the normal controls and correlated significantly with their clinical activity indices. In the UC patients, significant relationships were observed between the levels of plasma OPN and multiple cytokines, including interleukin (IL) -1β, IL-4, IL-5, IL-6, IL-7, IL-13, interferon-γ, tumor necrosis factor-α, and granulocyte-macrophage colony-stimulating factor. In the CD patients, the correlation was not significant except for IL-8. Our findings reflect different inflammatory states of the colon and rectum in both diseases.

Entities:  

Keywords:  Crohn's disease; Cytokine; Inflammatory bowel disease; Osteopontin; Ulcerative colitis

Mesh:

Substances:

Year:  2015        PMID: 25594638      PMCID: PMC4301292          DOI: 10.9738/INTSURG-D-13-00160.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  21 in total

1.  Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum.

Authors:  N Gassler; F Autschbach; S Gauer; J Bohn; B Sido; H F Otto; H Geiger; N Obermüller
Journal:  Scand J Gastroenterol       Date:  2002-11       Impact factor: 2.423

2.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

3.  The disease activity of ulcerative colitis and Crohn's disease.

Authors:  I Talstad; E Gjone
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

4.  Enhanced local production of osteopontin in rheumatoid joints.

Authors:  Shiro Ohshima; Norihiko Yamaguchi; Katsuhiro Nishioka; Toru Mima; Taeko Ishii; Mitsuko Umeshita-Sasai; Hideyuki Kobayashi; Masatoshi Shimizu; Yoshinori Katada; Shigeyuki Wakitani; Norikazu Murata; Shintaro Nomura; Hiroaki Matsuno; Rie Katayama; Shigeyuki Kon; Manabu Inobe; Toshimitsu Uede; Ichiro Kawase; Yukihiko Saeki
Journal:  J Rheumatol       Date:  2002-10       Impact factor: 4.666

5.  Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.

Authors:  Kenji Yumoto; Muneaki Ishijima; Susan R Rittling; Kunikazu Tsuji; Yoko Tsuchiya; Shigeyuki Kon; Akira Nifuji; Toshimitsu Uede; David T Denhardt; Masaki Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  Distinct gene expression of osteopontin in patients with ulcerative colitis.

Authors:  Hideki Masuda; Yasuo Takahashi; Satoshi Asai; Tadatoshi Takayama
Journal:  J Surg Res       Date:  2003-05-01       Impact factor: 2.192

8.  Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.

Authors:  Mario H J Vogt; Luba Lopatinskaya; Monique Smits; Chris H Polman; Lex Nagelkerken
Journal:  Ann Neurol       Date:  2003-06       Impact factor: 10.422

Review 9.  The immunological and genetic basis of inflammatory bowel disease.

Authors:  Gerd Bouma; Warren Strober
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

10.  Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.

Authors:  J Agnholt; J Kelsen; L Schack; C L Hvas; J F Dahlerup; E S Sørensen
Journal:  Scand J Immunol       Date:  2007-05       Impact factor: 3.487

View more
  9 in total

1.  Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.

Authors:  Margaret Delday; Imke Mulder; Elizabeth T Logan; George Grant
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

Review 2.  Osteopontin in autoimmune disorders: current knowledge and future perspective.

Authors:  Canhua Xu; Yaohong Wu; Ning Liu
Journal:  Inflammopharmacology       Date:  2022-03-02       Impact factor: 5.093

Review 3.  Osteopontin in Immune-mediated Diseases.

Authors:  S R Rittling; R Singh
Journal:  J Dent Res       Date:  2015-09-04       Impact factor: 6.116

4.  A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis.

Authors:  V B Freitas Alves; B Coutinho de Sousa; M Thaís Costa Fonseca; H Ogata; C Caliári-Oliveira; J Navarro Ueda Yaochite; V Rodrigues Júnior; J E Lazo Chica; J Santana da Silva; K C Ribeiro Malmegrim; L Pernomian; C Ribeiro Cardoso
Journal:  Clin Exp Immunol       Date:  2019-02-17       Impact factor: 4.330

5.  Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.

Authors:  Rikako Ishigamori; Masami Komiya; Shinji Takasu; Michihiro Mutoh; Toshio Imai; Mami Takahashi
Journal:  Int J Mol Sci       Date:  2017-05-14       Impact factor: 5.923

Review 6.  Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.

Authors:  Nausicaa Clemente; Davide Raineri; Giuseppe Cappellano; Elena Boggio; Francesco Favero; Maria Felicia Soluri; Chiara Dianzani; Cristoforo Comi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  J Immunol Res       Date:  2016-12-20       Impact factor: 4.818

7.  Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.

Authors:  Jeneen Panezai; Ambereen Ghaffar; Mohammad Altamash; Per-Erik Engström; Anders Larsson
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

8.  Circulating Profile of ECM-Related Proteins as Diagnostic Markers in Inflammatory Bowel Diseases.

Authors:  Katarzyna Komosinska-Vassev; Aleksandra Kałużna; Agnieszka Jura-Półtorak; Alicja Derkacz; Krystyna Olczyk
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

9.  Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model.

Authors:  Huicun Zhang; Na Ta; Hong Shen; Hongbing Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.